Human papillomavirus genotype detection from Archival Papanicolaou-stained cervical tests

Cancer Cytopathology

Volumn 118, Issue 6, 2010, Pages 482-489

  Tabrizi, Sepehr N ^a,b   Taylor, Nicole ^a   McCullough, Michael J ^c   Phillips, Gillian ^d   Wark, John ^b   Gertig, Dorota ^e   Petersen, Rodney W ^f   Saville, Marion ^d   Garland, Suzanne M ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d VICTORIAN CYTOLOGY SERVICE   (Australia)

^e Victorian Cervical Cytology Registry Melbourne   (Australia)

^f EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Cervical cancer; Digital imaging; HPV detection; HPV genotyping; Human papillomavirus (HPV); Papanicolaou test; Polymerase chain reaction

Indexed keywords

VIRUS DNA;

ARTICLE; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; VAGINA SMEAR;

DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; VAGINAL SMEARS;

EID: 79951613398     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20117     Document Type: Article

References (28)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
2. Kjaer SK, van den Brule AJ, Bock JE, et al. Human papillomavirus- the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer. 1996;65:601-606.
3. Munoz N, Bosch FX. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Organ. 1996;30:362-377.
4. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
5. Munoz N, Bosch FX, de Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52:743-749.
6. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
8. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17-27.
9. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63-73.
10. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000;19:1-5.
11. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278-285.
12. Jackson DP, Bell S, Payne J, et al. Extraction and amplification of DNA from archival haematoxylin and eosin sections and cervical cytology Papanicolaou smears. Nucleic Acids Res. 1989;17:10134.
13. Jackson DP, Payne J, Bell S, et al. Extraction of DNA from exfoliative cytology specimens and its suitability for analysis by the polymerase chain reaction. Cytopathology. 1990;1:87-96.
14. Poljak M, Seme K, Barlic J. Processing of long-stored archival Papanicolaou-stained cytological smears. Br J Cancer. 1996;74:1508-1509.
15. Gall K, Pavicic D, Pavelic J, Audy-Jurkovic S, Pavelic K. PCR amplification of DNA from stained cytological smears. J Clin Pathol. 1993;46:378-379.
16. Jacobs MV, Zielinski D, Meijer CJ, et al. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer. 2000;82:1421-1426.
17. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer. 1995;72:412-417.
18. Chua KL, Hjerpe A. Polymerase chain reaction analysis of human papillomavirus in archival cervical cytologic smears. Anal Quant Cytol Histol. 1995;17:221-229.
19. Stevens MP, Garland SM, Tan JH, Quinn MA, Petersen RW, Tabrizi SN. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. J Med Virol. 2009;81:1283-1291.
20. Stevens MP, Rudland E, Garland SM, Tabrizi SN. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol. 2006;44:2428-2433.
21. Stevens MP, Garland SM, Tabrizi SN. Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods. 2006;135:124-126.
22. Stevens MP, Garland SM, Tabrizi SN. Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test. J Clin Microbiol. 2008;46:3813-3816.
23. Coutlee F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol. 2006;44: 1998-2006.
24. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
25. Stevens MP, Garland SM, Tabrizi SN. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods. 2008;147:290-296.
26. Stevens MP, Garland SM, Rudland E, Tan J, Quinn MA, Tabrizi SN. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol. 2007;45: 2130-2137.
27. National Pathology Accreditation Advisory Council. Requirements for the Retention of Laboratory Records and Diagnostic Material. Canberra, Australian Capital Territory, Australia: National Pathology Accreditation Advisory Council; 2009.
28. Pantanowitz L, Hornish M, Goulart RA. The impact of digital imaging in the field of cytopathology. Cytojournal. 2009;6:6.